Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Health & MedicineOne-Off1yManifold MarketsKYC yokDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel topluluk tahminiHayır 79.4%
Tahminciler
3
Soru türü
binary
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
Piyasa verileri
1 saat önce güncellendi
Gecikmeli21 Şub 23 20:25 UTC31 Ara 27 22:59 UTC
Trendler
Kurallar
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
Sık sorulan sorular
- Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? için güncel oranlar nedir?
- Manifold Markets, 8 Eylül 2026 itibarıyla No için 79% fiyatlıyor.
- Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? ne zaman sonuçlanacak?
- Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? için öngörülen sonuçlanma tarihi 31 Aralık 2027.
- Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028? nasıl sonuçlandırılıyor?
- Manifold Markets bu piyasayı şu şekilde sonuçlandırır: Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of prostate adenocarcinoma in the United States before January 1, 2028.
